Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis

Brain

Volumn 118, Issue 6, 1995, Pages 1601-1612

  Filippi, M ^a   Horsfield, M A ^b   Tofts, P S ^c   Barkhof, F ^d   Thompson, A J ^c   Miller, D H ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Disability; Lesion volume; MRI; Multiple sclerosis; Quantitative assessment

Indexed keywords

GADOLINIUM;

ARTICLE; DIAGNOSTIC VALUE; HUMAN; IMAGE PROCESSING; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REPRODUCIBILITY; TREATMENT OUTCOME;

BRAIN; DISEASE PROGRESSION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS;

EID: 0029568036     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/118.6.1601     Document Type: Review

References (103)

1. Arnett PA, Rao SM, Bernardin L, Grafman J, Yetkin FZ, Lobeck L. Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis. Neurology 1994; 44: 420-5.
2. Arnold DL, Riess GT, Matthews PM, Francis GS, Collins DL, Wolfson C, et al. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol 1994; 36: 76-82.
3. Baratti C, Barkhof F, Hoogernaad J, Valk J. Fluid attenuated inversion recovery (FLAIR) sequences in multiple sclerosis: contrast parameters in a steady state and comparison with spin echo sequences. Magn Reson Imaging 1995. In press.
4. Barbosa S, Blumhardt LD, Roberts N, Lock T, Edwards RHT. Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white matter and the ‘invisible’ lesion load. Magn Reson Imaging 1994; 12: 33-42.
5. Barkhof F, Scheltens P, Frequin STFM, Nauta JJP, Tas MW, Valk J, et al. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. AJR Am J Roentgenol 1992; 159: 1041-7.
6. Barnes D, McDonald WI, Johnson G, Tofts PS, Landon DN. Quantitative nuclear magnetic resonance imaging: characterisation of experimental cerebral oedema. J Neurol Neurosurg Psychiatry 1987; 50: 125-33.
7. Barnes D, McDonald WI, Landon DN, Johnson G. The characterization of experimental gliosis by quantitative nuclear magnetic resonance imaging. Brain 1988; 111: 83-94.
8. Barnes D, Munro PMG, Youl BD, Prineas JW, McDonald WI. The longstanding MS lesion. A quantitative MRI and electron microscopic study. Brain 1991; 114: 1271-80.
9. Baumhefner RW, Tourtellotte WW, Syndulko K, Waluch V, Ellison GW, Meyers LW, et al. Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging. Its correlation with clinical parameters, evoked potentials, and intra-blood-brain barrier IgG synthesis. Arch Neurol 1990; 47: 19-26.
10. Bottomley PA, Foster TH, Argersinger RE, Pfeifer LM. A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1-100 MHz: dependence of tissue type, NMR frequency, temperature, species, excision, and age. Med Phys 1984; 11: 425-18.
11. Bradley WG, Chen D, Goergen SK, Tam JK, Dubin MD, Pema PJ. Use of thin-section fast FLAIR to evaluate multiple sclerosis [abstract]. Radiology 1994; 193 Suppl: 320.
12. Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple sclerosis with special reference to cerebral plaques. J Neurol Neurosurg Psychiatry 1962; 25: 315-20.
13. Bruck W, Schmied M, Suchanek G, Bruck Y, Breitschopf H, Poser S, et al. Oligodendrocytes in the early course of multiple sclerosis. Ann Neurol 1994; 35: 65-73.
14. Capra R, Marciano N, Vignolo LA, Chiesa A, Gasparotti R. Gadolinium-pentetic acid magnetic resonance imaging in patients with relapsing remitting multiple sclerosis [see comments]. Arch Neurol 1992; 49: 687-9.
15. Capra R, Marciano N, Vignolo LA, Chiesa A, Gasparotti R. Comment in: Arch Neurol 1992; 49: 6856.
16. Capra R, Marciano N, Vignolo LA, Chiesa A, Gasparotti R. Cornent in: Arch Neurol 1993; 50: 569-71.
17. Clarke LP, Velthuizen RP, Camacho MA, Heine J J, Vaidyanathan M, Hall LO, et al. MRI segmentation: methods and applications. Magn Reson Imaging 1995; 13: 343-68.
18. Cline HE, Lorensen WE, Kikinis R, Jolesz F. Three-dimensional segmentation of MR images of the head using probability and connectivity. J Comput Assist Tomogr 1990; 14: 1037-45.
19. Collins DL, Neelin P, Peters TM, Evans AC. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 1994; 18: 192-205.
20. Constable RT, Gore JC. The loss of small objects in variable TE imaging: implications for FSE, RARE and EPI. Magn Reson Med 1992; 28: 9-24.
21. Davie CA, Barker GJ, Webb S, McDonald WI, Miller DH. Proton magnetic resonance spectroscopy (MRS) study of cerebellar dysfunction in multiple sclerosis [abstract]. J Neurol 1994: 241 Suppl 1: S151.
22. Dousset V, Grossman RI, Ramer KN, Schnall MD, Young LH, Gonzales-Scarano F, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging [published erratum appears in Radiology 1992: 183: 878]. Radiology 1992; 182: 483-91.
23. Filippi M, Barker GJ, Horsfield MA, Sacares PR, MacManus DG, Thompson AJ, et al. Benign and secondary progressive multiple sclerosis: A preliminary quantitative MRI study. J Neurol 1994a; 241: 246-51.
24. Filippi M, Horsfield MA, Morrissey SP, MacManus DG, Rudge P, McDonald WI, et al. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology 1994b; 44: 635-41.
25. Filippi M, Campi A, Dousset V, Baratti C, Martinelli V, Canal N, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995a; 45: 478-82.
26. Filippi M, Horsfield MA, Bressi S, Martinelli V, Baratti C, Reganati P, et al. Intra-and inter-observer variability of brain MRI lesion volume measurements in multiple sclerosis: A comparison of techniques. Brain 1995b; 118: 1593-1600.
27. Filippi M, Horsfield MA, Campi A, Mammi S, Pereira C, Comi G. Resolution-dependent estimates of lesion volumes in MRI studies of the brain in multiple sclerosis. Ann Neurol 1995. In press.
28. Filippi M, Paty DW, Kappos L, Barkhof F, Compston DAS, Thompson AJ, et al. Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: A follow-up study. Neurology 1995d; 45: 255-60.
29. Filippi M, Rovaris M, Campi A, Pereira C, Comi G. Semi-automated thresholding technique for mesuring lesion volumes in multiple sclerosis: effects of change of the threshold on the computed lesion loads. Acta Neurol Scand 1995. In press.
30. Gass A, Barker GJ, Kidd D, Thorpe JW, MacManus D, Brennan A, et al. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol 1994; 36: 62-7.
31. Gebarski SS, Gabrielsen TO, Gilman S, Knake JE, Latack JT, Aisen AM. The initial diagnosis of multiple sclerosis: clinical impact of magnetic resonance imaging. Ann Neurol 1985; 17: 469-74.
32. Grimaud J, Lai M, Thorpe JW, Adeleine P, Plummer D, Barker GJ, et al. Evaluation of a computer-assisted quantification of MS lesions in cranial MRI [abstract]. J Neurol Neurosurg Psychiatry 1995. In press.
33. Hajnal JV, Bryant DJ, Kasuboski L, Pattany PM, De Coene B, Lewis PD, et al. Use of fluid attenuated inversion recovery (FLAIR) pulse sequences in MRI of the brain. J Comput Assist Tomogr 1992; 16: 841-4.
34. Harris JO, Frank JA, Patronas N, McFarlin DE, McFarland HF. Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol 1991; 29: 548-55.
35. Haughton VM, Yetkin FZ, Rao SM, Rimm AA, Fischer ME, Papke RA, et al. Quantitative MR in the diagnosis of multiple sclerosis. Magn Reson Med 1992; 26: 71-8.
36. Hennig J, Nauerth A, Friedburg H. RARE imaging: A fast imaging method for clinical MR. Magn Reson Med 1986; 3: 823-33.
37. Hiehle JF, Grossman RI, Ramer KN, Gonzales-Scarano F, Cohen JA. Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced TI-weighted images. AJNR Am J Neuroradiol 1995; 16: 69-77.
38. IFNB Multiple Sclerosis Study Group. Interferon beta-1 b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial [see comments]. Neurology 1993: 43: 655-61.
39. IFNB Multiple Sclerosis Study Group Comment in: Neurology 1993; 43: 641-3.
40. Isaac C, Li DBK, Genton M, Jardine C, Grochowski E, Palmer M, et al. Multiple sclerosis: A serial study using MRI in relapsing patients. Neurology 1988; 38: 1511-15.
41. Kapouleas I, Grossman RI, Kessler D, Borstein J, Cohen J, Ramer K. Techniques for quantitation and comparison of multiple sclerosis lesions in serial MRI studies [abstract]. Neurology 1993; 43 (4 Suppl 2): A246.
42. Kappos L, Stadt D, Ratzka M, Keil W, Schneiderbanger-Grygier S, Heitzer T, et al. Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis. Neuroradiology 1988; 30: 299-302.
43. Kastrukoff LF, Oger JJ, Hashimoto SA, Sacks SL, Li DK, Palmer MR, et al. Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. 1. Clinical and MRI evaluation. Neurology 1990; 40: 479-86.
44. Kidd D, Thorpe JW, Thompson AJ, Kendall BE, Moseley IF, MacManus DG, et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993; 43: 2632-7.
45. Kohn MI, Tanna NK, Herman GT, Resnick SM, Mozley PD, Gur RE, et al. Analysis of brain and cerebrospinal fluid volumes with MR imaging. Part 1. Methods, reliability, and validation [see comments]. Radiology 1991; 178: 115-22.
46. Kohn MI, Tanna NK, Herman GT, Resnick SM, Mozley PD, Gur RE, et al. Comment in: Radiology 1991; 178: 22-4.
47. Kohn MI, Tanna NK, Herman GT, Resnick SM, Mozley PD, Gur RE, et al. Comment in: Radiology 1992; 183: 876-7.
48. Koopmans RA, Li DK, Grochowski E, Cutler PJ, Paty DW. Benign versus chronic progressive multiple sclerosis: magnetic resonance imaging features. Ann Neurol 1989; 25: 74-81.
49. Koopmans RA, Li DKB, Zhao GJ, Redekop WK, Paty DW. MRI assessment of cyclosporine therapy of MS in a multi-center trial [abstract]. Neurology 1992; 42 (Suppl 3): 210.
50. Koopmans RA, Li DBK, Redekop WK, Zhao GJ, Palmer MR, Kastrukoff LF, et al. The use of magnetic resonance imaging in monitoring interferon therapy of multiple sclerosis. J Neuroimaging 1993; 3: 163-8.
51. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
52. Larsson HBW, Frederiksen J, Kyaer L, Henriksen O, Olesen J. In vivo determination of T and T2 in the brain of patients with severe but stable multiple sclerosis. Magn Reson Med 1988; 7: 43-55.
53. Larsson HBW, Frederiksen J, Petersen J, Nordenbo A, Zeeberg I, Henriksen O, et al. Assessment of demyelination, edema, and gliosis by in vivo determination of T and T2 in the brain of patients with acute attack of multiple sclerosis. Magn Reson Med 1989; 11: 337-48.
54. Litt AW, Moore JR. Improved detection of white matter pathology with turbo-FLAIR MR imaging [abstract]. Radiology 1994; 193 (Suppl): 320.
55. Lukes SA, Crooks LE, Aminoff MJ, Kaufman L, Panitch HS, Mills C, et al. Nuclear magnetic resonance imaging in multiple sclerosis. Ann Neurol 1983; 13: 592-601.
56. Lumsden CE. The neuropathology of multiple sclerosis. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology, Vol. 9. Amsterdam: North-Holland, 1970: 296-8.
57. McDonald WI. The dynamics of multiple sclerosis. The Charcot Lecture. J Neurol 1993; 240: 28-36.
58. McDonald WI, Miller DH, Barnes D. The pathological evolution of multiple sclerosis. [Review], Neuropathol Appl Neurobiol 1992; 18: 319-34.
59. McDonald WI, Miller DH, Thompson AJ. Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta. [Review], Ann Neurol 1994; 36: 14-18.
60. McFarland HF, Frank JA, Albert PS, Smith ME, Martin R, Harris JO, et al. Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol 1992; 32: 758-66.
61. Miller DH. Magnetic resonance in monitoring the treatment of multiple sclerosis. [Review], Ann Neurol 1994; 36 Suppl: 891-4.
62. Miller DH, Rudge P, Johnson G, Kendall BE, MacManus DG, Moseley IF, et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 1988; 111: 927-39.
63. Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines [see comments]. J Neurol Neurosurg Psychiatry 1991; 54: 683-8.
64. Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Comment in: J Neurol Neurosurg Psychiatry 1992; 55: 978.
65. Miller DH, Barkhof F, Nauta JJP. Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 1993; 116: 1077-94.
66. Mitchell JR, Karlik SJ, Lee DH, Fenster A. Computer-assisted identification and quantification of multiple sclerosis lesions in MR imaging volumes in the brain. J Magn Reson Imaging 1994; 4: 197-208.
67. Multiple Sclerosis Study Group. Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: A randomized, double-blinded, placebo-controlled clinical trial [see comments]. Ann Neurol 1990; 27: 591-605.
68. Multiple Sclerosis Study Group.Comment in: Ann Neurol 1991; 29: 226.
69. Nauta JJP, Thompson AJ, Barkhof F, Miller DH. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients: statistical power of parallel-groups and crossover designs. J Neurol Sci 1994; 122: 6-14.
70. Noseworthy JH, Vandervoort MK, Wong CJ, Ebers GC. Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group [see comments] Neurology 1990; 40: 971-5.
71. Noseworthy JH, Vandervoort MK, Wong CJ, Ebers GC. Comment in: Neurology 1991; 41: 332.
72. Ormerod IEC, Miller DH, McDonald WI, du Boulay EPGH, Rudge P, Kendall BE, et al. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain 1987; 110: 1579-616.
73. Pannizzo F, Stallmeyer MJB, Friedman J, Jennis RJ, Zabriskie J, Plank C, et al. Quantitative MRI studies for assessment of multiple sclerosis. Magn Reson Med 1992; 24: 90-9.
74. Paty DW, Li DK, UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial [see comments]. Neurology 1993; 43: 662-7.
75. Paty DW, Li DK, Comment in: Neurology 1993; 43: 641-3.
76. Paty DW, Li DK, Oger JJF, Kastrukoff L, Koopmans R, Tanton E, et al. Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis. Ann Neurol 1994; 36 Suppl: 895-6.
77. Prineas JW, Kwon EE, Goldenberg PZ, Ilyas AA, Quarles RH, Benjamins JA, et al. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions. Lab Invest 1989; 61: 489-503.
78. Prineas JW, Barnard RO, Kwon EE, Shorer LR, Cho ES. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 1993; 33: 137-51.
79. Raine CS, Scheinberg L, Waltz JM. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion. Lab Invest 1981; 45: 534-46.
80. Rao SM, Leo GJ, Haughton VM, St Aubin-Faubert P, Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989; 39: 161-6.
81. Rydberg JN, Hammond CA, Grimm RC, Erickson BJ, Jack CR Jr, Huston J 3rd, et al. Initial clinical experience in MR imaging of the brain with a fast fluid-attenuated inversion-recovery pulse sequence. Radiology 1994; 193: 173-80.
82. Simmons A, Arridge SR, Barker GJ, Cluckie AJ, Tofts PS. Improvements to the quality of MRI cluster analysis. Magn Reson Imaging 1994; 12: 1191-204.
83. Smith ME, Stone LA, Albert PS, Frank JA, Martin R, Armstrong M, et al. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol 1993; 33: 480-9.
84. Stone LA, Albert PS, Smith ME, DeCarli C, Armstrong MR, McFarlin DE, et al. Changes in the amount of diseases white matter over time in patients with relapsing remitting multiple sclerosis. Neurology 1995. In press.
85. Swirski-Sacchetti T, Mitchell DR, Seward J, Gonzales C, Lublin F, Knobler R, et al. Neuropsychological and structural brain lesions in multiple sclerosis: A regional analysis. Neurology 1992; 42: 1291-5.
86. Thomas DJ, Pennock JM, Hajnal JV, Young IR, Bydder GM, Steiner RE. Magnetic resonance imaging of spinal cord in multiple sclerosis by fluid-attenuated inversion recovery [see comments]. Lancet 1993; 341: 593-4.
87. Thomas DJ, Pennock JM, Hajnal JV, Young IR, Bydder GM, Steiner RE. Comment in: Lancet 1993; 341: 1025.
88. Thompson AJ, Kermode AG, MacManus DG, Kendall BE, Kingsley DPE, Moseley IF, et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study [see comments]. BMJ 1990; 300: 631-1.
89. Thomas DJ, Pennock JM, Hajnal JV, Young IR, Bydder GM, Steiner RE. Comment in: BMJ 1990; 300: 1272.
90. Thompson AJ, Kermode AG, Wicks D, MacManus DG, Kendall BE, Kingsley DPE, et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991; 29: 53-62.
91. Thompson AJ, Miller DH, Youl B, MacManus DG, Moore S, Kingsley DPE, et al. Serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosis of varying disease duration. Neurology 1992; 42: 60-3.
92. Thorpe JW, Kidd D, Kendall BE, Tofts PS, Barker GJ, Thompson AJ, et al. Spinal cord MRI using multi-array coils and fast spin echo. I. Technical aspects and findings in healthy adults. Neurology 1993; 43: 2625-31.
93. Thorpe JW, Barker GJ, MacManus DG, Moseley IF, Tofts PS, Miller DH. Detection of multiple sclerosis by magnetic resonance imaging [letter]. Lancet 1994a; 344: 1235.
94. Thorpe JW, Halpin SF, MacManus DG, Barker GJ, Kendall BE, Miller DH. A comparison between fast and conventional spin-echo in the detection of multiple sclerosis lesions. Neuroradiology 1994b; 36: 388-92.
95. Uhlenbrock D, Sehlen S. The value of T-weighted images in the differentiation between MS, white matter lesions, and subcortical arteriosclerotic encephalopathy (SAE). [Review], Neuroradiology 1989; 31: 203-12.
96. van Walderveen MAA, Barkhof F, Hommes OR, Polman CH, Tobi H, Frequin STFM, et al. Correlating MR imaging and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short TR/short TE (‘T-weighted’) spin-echo images. Neurology 1995. In press.
97. Wicks DAG, Tofts PS, Miller DH, du Boulay GH, Feinstein A, Sacares RP, et al. Volume measurement of multiple sclerosis lesions with magnetic resonance images: A preliminary study. Neuroradiology 1992; 34: 475-9.
98. Wicks DAG, Barker GJ, Tofts PS. Correction of intensity nonuniformity in MR images of any orientation. Magn Reson Imaging 1993; 11: 183-96.
99. Wiebe S, Lee DH, Karlik SJ, Hopkins M, Vandervoort MK, Wong CJ, et al. Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis. Ann Neurol 1992; 32: 643-50.
100. Wiles CM, Omar L, Swan AV, Sawle G, Frankel J, Grünewald R, et al. Total lymphoid irradiation in multiple sclerosis. J Neurol Neurosurg Psychiatry 1994; 57: 154-63.
101. Willoughby EW, Grochowski E, Li DK, Oger J, Kastrukoff LF, Paty DW. Serial magnetic resonance scanning in multiple sclerosis: A second prospective study in relapsing patients. Ann Neurol 1989; 25: 43-9.
102. Youl BD, Turano G, Miller DH, Towell AD, MacManus DG, Moore SG, et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain 1991; 114: 2437-50.
103. Young IR, Hall AS, Pallis CA, Legg NJ, Bydder GM, Steiner RE. Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet 1981; 2: 1063-6.